HK Stock Market Move | CHONGQING M&E (02722) surged over 8% at the close, hitting a record high. The North American power shortage logic continues to deepen.
Chongqing Machinery and Electric Co., Ltd. (02722) surged more than 8% in the last trading session, reaching a high of HK$3.68, a new historical high.
Chongqing M&E (02722) rose more than 8% in the final trading session, hitting a high of 3.68 Hong Kong dollars, a new historical record. As of the time of publication, it had risen by 8.55% to 3.68 Hong Kong dollars, with a trading volume of 107 million Hong Kong dollars.
On the news front, it was reported that several US technology giants are planning to visit the White House next week to meet with President Trump, during which they will sign written documents committing to supply or purchase the electricity needed for artificial intelligence data centers. EB Securities believes that the power shortage in the US has increased the demand for power system reliability, and gas turbines, power equipment, and other sectors are expected to benefit fully. Industrial previously pointed out that Chongqing M&E is also involved in Chongqing Cummins and Chongqing Hitachi Energy, and the two major growth segments in the future will benefit from data center and power grid construction.
Related Articles

ZERO FINTECH (00093) issues profit warning: It is expected that the pre-tax profit for the year 2025 will not be less than approximately HK$25 million.

SINO LAND (00083) will distribute an interim dividend of 0.15 Hong Kong dollars per share on April 23rd.

SSY GROUP (02005): Medical recombinant collagen peptide gynecological gel and B-type natriuretic peptide (BNP) detection kit (fluorescence immunochromatography method) has been awarded a medical device registration certificate by the Hebei Food and Drug Administration.
ZERO FINTECH (00093) issues profit warning: It is expected that the pre-tax profit for the year 2025 will not be less than approximately HK$25 million.

SINO LAND (00083) will distribute an interim dividend of 0.15 Hong Kong dollars per share on April 23rd.

SSY GROUP (02005): Medical recombinant collagen peptide gynecological gel and B-type natriuretic peptide (BNP) detection kit (fluorescence immunochromatography method) has been awarded a medical device registration certificate by the Hebei Food and Drug Administration.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


